155 related articles for article (PubMed ID: 16790528)
1. SAP155 Binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5' splice site selection of Bcl-x pre-mRNA.
Massiello A; Roesser JR; Chalfant CE
FASEB J; 2006 Aug; 20(10):1680-2. PubMed ID: 16790528
[TBL] [Abstract][Full Text] [Related]
2. The Proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-mRNA.
Shultz JC; Vu N; Shultz MD; Mba MU; Shapiro BA; Chalfant CE
Mol Cancer Res; 2012 May; 10(5):660-9. PubMed ID: 22522453
[TBL] [Abstract][Full Text] [Related]
3. Identification of two RNA cis-elements that function to regulate the 5' splice site selection of Bcl-x pre-mRNA in response to ceramide.
Massiello A; Salas A; Pinkerman RL; Roddy P; Roesser JR; Chalfant CE
J Biol Chem; 2004 Apr; 279(16):15799-804. PubMed ID: 14734550
[TBL] [Abstract][Full Text] [Related]
4. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1.
Chalfant CE; Rathman K; Pinkerman RL; Wood RE; Obeid LM; Ogretmen B; Hannun YA
J Biol Chem; 2002 Apr; 277(15):12587-95. PubMed ID: 11801602
[TBL] [Abstract][Full Text] [Related]
5. Antagonistic effects of the SRp30c protein and cryptic 5' splice sites on the alternative splicing of the apoptotic regulator Bcl-x.
Cloutier P; Toutant J; Shkreta L; Goekjian S; Revil T; Chabot B
J Biol Chem; 2008 Aug; 283(31):21315-24. PubMed ID: 18534987
[TBL] [Abstract][Full Text] [Related]
6. SAP155-mediated splicing of FUSE-binding protein-interacting repressor serves as a molecular switch for c-myc gene expression.
Matsushita K; Kajiwara T; Tamura M; Satoh M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Yoshimoto R; Ito A; Kubo S; Natsume T; Levens D; Yoshida M; Nomura F
Mol Cancer Res; 2012 Jun; 10(6):787-99. PubMed ID: 22496461
[TBL] [Abstract][Full Text] [Related]
7. Nuclear inhibitor of protein phosphatase-1 (NIPP1) directs protein phosphatase-1 (PP1) to dephosphorylate the U2 small nuclear ribonucleoprotein particle (snRNP) component, spliceosome-associated protein 155 (Sap155).
Tanuma N; Kim SE; Beullens M; Tsubaki Y; Mitsuhashi S; Nomura M; Kawamura T; Isono K; Koseki H; Sato M; Bollen M; Kikuchi K; Shima H
J Biol Chem; 2008 Dec; 283(51):35805-14. PubMed ID: 18842582
[TBL] [Abstract][Full Text] [Related]
8. Group VIA Phospholipase A2 (iPLA2β) Modulates Bcl-x 5'-Splice Site Selection and Suppresses Anti-apoptotic Bcl-x(L) in β-Cells.
Barbour SE; Nguyen PT; Park M; Emani B; Lei X; Kambalapalli M; Shultz JC; Wijesinghe D; Chalfant CE; Ramanadham S
J Biol Chem; 2015 Apr; 290(17):11021-31. PubMed ID: 25762722
[TBL] [Abstract][Full Text] [Related]
9. Relative strength of 5' splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA.
Choi N; Liu Y; Oh J; Ha J; Ghigna C; Zheng X; Shen H
BMB Rep; 2021 Mar; 54(3):176-181. PubMed ID: 33050987
[TBL] [Abstract][Full Text] [Related]
10. Interactions between SAP155 and FUSE-binding protein-interacting repressor bridges c-Myc and P27Kip1 expression.
Matsushita K; Tamura M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Levens D; He L; Liu J; Yoshida M; Nomura F
Mol Cancer Res; 2013 Jul; 11(7):689-98. PubMed ID: 23594796
[TBL] [Abstract][Full Text] [Related]
11. SRp30a (ASF/SF2) regulates the alternative splicing of caspase-9 pre-mRNA and is required for ceramide-responsiveness.
Massiello A; Chalfant CE
J Lipid Res; 2006 May; 47(5):892-7. PubMed ID: 16505493
[TBL] [Abstract][Full Text] [Related]
12. SAP155-mediated c-myc suppressor far-upstream element-binding protein-interacting repressor splicing variants are activated in colon cancer tissues.
Kajiwara T; Matsushita K; Itoga S; Tamura M; Tanaka N; Tomonaga T; Matsubara H; Shimada H; Habara Y; Matsuo M; Nomura F
Cancer Sci; 2013 Feb; 104(2):149-56. PubMed ID: 23113893
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylated SAP155, the spliceosomal component, is localized to chromatin in postnatal mouse testes.
Eto K; Sonoda Y; Jin Y; Abe S
Biochem Biophys Res Commun; 2010 Mar; 393(4):577-81. PubMed ID: 20153721
[TBL] [Abstract][Full Text] [Related]
14. Novel splicing factor RBM25 modulates Bcl-x pre-mRNA 5' splice site selection.
Zhou A; Ou AC; Cho A; Benz EJ; Huang SC
Mol Cell Biol; 2008 Oct; 28(19):5924-36. PubMed ID: 18663000
[TBL] [Abstract][Full Text] [Related]
15. Bcl-x pre-mRNA splicing regulates brain injury after neonatal hypoxia-ischemia.
Xiao Q; Ford AL; Xu J; Yan P; Lee KY; Gonzales E; West T; Holtzman DM; Lee JM
J Neurosci; 2012 Sep; 32(39):13587-96. PubMed ID: 23015448
[TBL] [Abstract][Full Text] [Related]
16. Pro-apoptotic effects of splice-switching oligonucleotides targeting Bcl-x pre-mRNA in human glioma cell lines.
Li Z; Li Q; Han L; Tian N; Liang Q; Li Y; Zhao X; Du C; Tian Y
Oncol Rep; 2016 Feb; 35(2):1013-9. PubMed ID: 26718027
[TBL] [Abstract][Full Text] [Related]
17. Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A.
Corrionero A; Miñana B; Valcárcel J
Genes Dev; 2011 Mar; 25(5):445-59. PubMed ID: 21363963
[TBL] [Abstract][Full Text] [Related]
18. Regulation of BCL-X splicing reveals a role for the polypyrimidine tract binding protein (PTBP1/hnRNP I) in alternative 5' splice site selection.
Bielli P; Bordi M; Di Biasio V; Sette C
Nucleic Acids Res; 2014 Oct; 42(19):12070-81. PubMed ID: 25294838
[TBL] [Abstract][Full Text] [Related]
19. Identification of SAP155 as the target of GEX1A (Herboxidiene), an antitumor natural product.
Hasegawa M; Miura T; Kuzuya K; Inoue A; Won Ki S; Horinouchi S; Yoshida T; Kunoh T; Koseki K; Mino K; Sasaki R; Yoshida M; Mizukami T
ACS Chem Biol; 2011 Mar; 6(3):229-33. PubMed ID: 21138297
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel cis-element that regulates alternative splicing of Bcl-x pre-mRNA.
Lee J; Zhou J; Zheng X; Cho S; Moon H; Loh TJ; Jo K; Shen H
Biochem Biophys Res Commun; 2012 Apr; 420(2):467-72. PubMed ID: 22440396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
